Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Short Communication

COVID Vaccines vs. Viral Evolution: Who Will Win the Battle?

Author(s): Sahil Sharma, Vikas Sood and Deepak Sharma*

Volume 26, Issue 14, 2023

Published on: 02 May, 2023

Page: [2572 - 2574] Pages: 3

DOI: 10.2174/1386207326666230328172918

Price: $65

Abstract

The emergence of new variants seems to perpetually prolong the COVID-19 pandemic. On top of that, the waning of vaccine protection is further thwarting our efforts to end it. Our article discusses the incessant question raging in everybody’s mind: Are we ever going to win?

« Previous
[1]
Desai, D.; Khan, A.R.; Soneja, M.; Mittal, A.; Naik, S.; Kodan, P.; Mandal, A.; Maher, G.T.; Kumar, R.; Agarwal, A.; Gowda, N.R.; H, V.; Kumar, P.; Pandey, S.; Pandey, R.M.; Kumar, A.; Ray, A.; Jorwal, P.; Nischal, N.; Choudhary, A.; Brijwal, M.; Madan, K.; Lodha, R.; Sinha, S.; Dar, L.; Wig, N.; Guleria, R. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: A test-negative, case-control study. Lancet Infect. Dis., 2022, 22(3), 349-356.
[http://dx.doi.org/10.1016/S1473-3099(21)00674-5] [PMID: 34826383]
[2]
Thiruvengadam, R.; Awasthi, A.; Medigeshi, G.; Bhattacharya, S.; Mani, S.; Sivasubbu, S.; Shrivastava, T.; Samal, S.; Rathna Murugesan, D.; Koundinya Desiraju, B.; Kshetrapal, P.; Pandey, R.; Scaria, V.; Kumar Malik, P.; Taneja, J.; Binayke, A.; Vohra, T.; Zaheer, A.; Rathore, D.; Ahmad Khan, N.; Shaman, H.; Ahmed, S.; Kumar, R.; Deshpande, S.; Subramani, C.; Wadhwa, N.; Gupta, N.; Pandey, A.K.; Bhattacharya, J.; Agrawal, A.; Vrati, S.; Bhatnagar, S.; Garg, P.K. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Lancet Infect. Dis., 2022, 22(4), 473-482.
[http://dx.doi.org/10.1016/S1473-3099(21)00680-0] [PMID: 34838183]
[3]
Mallapaty, S. Where did Omicron come from? Three key theories. Nature, 2022, 602(7895), 26-28.
[http://dx.doi.org/10.1038/d41586-022-00215-2] [PMID: 35091701]
[4]
WHO Coronavirus Disease (COVID-19) Dashboard 2022. Available from: https://covid19.who.int
[5]
Sharma, D. Viral evolution will automatically resolve COVID-19 pandemic. Comb. Chem. High Throughput Screen., 2020, 23(8), 686.
[http://dx.doi.org/10.2174/1386207323666200724150726] [PMID: 32713339]
[6]
Sharma, D. Shalimar, COVID-19: Finally on wane, with reduced lethality. Comb. Chem. High Throughput Screen., 2022, 25(5), 768-770.
[http://dx.doi.org/10.2174/1386207324666210811130046] [PMID: 34382508]
[7]
Taylor, L. Why scientists worldwide are watching UK COVID infections. Nature, 2021, 599(7884), 189-190.
[http://dx.doi.org/10.1038/d41586-021-03003-6] [PMID: 34732879]
[8]
Wheatley, A.K.; Juno, J.A. COVID-19 vaccines in the age of the delta variant. Lancet Infect. Dis., 2022, 22(4), 429-430.
[http://dx.doi.org/10.1016/S1473-3099(21)00688-5] [PMID: 34838184]
[9]
Murray, C.J.L.; Piot, P. The potential future of the COVID-19 pandemic. JAMA, 2021, 325(13), 1249-1250.
[http://dx.doi.org/10.1001/jama.2021.2828] [PMID: 33656519]
[10]
Kozlov, M. Omicron’s feeble attack on the lungs could make it less dangerous. Nature, 2022, 601(7892), 177.
[http://dx.doi.org/10.1038/d41586-022-00007-8] [PMID: 34987210]
[11]
Wang, L.; Zhou, T.; Zhang, Y.; Yang, E.S.; Schramm, C.A.; Shi, W.; Pegu, A.; Oloniniyi, O.K.; Henry, A.R.; Darko, S.; Narpala, S.R.; Hatcher, C.; Martinez, D.R.; Tsybovsky, Y.; Phung, E.; Abiona, O.M.; Antia, A.; Cale, E.M.; Chang, L.A.; Choe, M.; Corbett, K.S.; Davis, R.L.; DiPiazza, A.T.; Gordon, I.J.; Hait, S.H.; Hermanus, T.; Kgagudi, P.; Laboune, F.; Leung, K.; Liu, T.; Mason, R.D.; Nazzari, A.F.; Novik, L.; O’Connell, S.; O’Dell, S.; Olia, A.S.; Schmidt, S.D.; Stephens, T.; Stringham, C.D.; Talana, C.A.; Teng, I.T.; Wagner, D.A.; Widge, A.T.; Zhang, B.; Roederer, M.; Ledgerwood, J.E.; Ruckwardt, T.J.; Gaudinski, M.R.; Moore, P.L.; Doria-Rose, N.A.; Baric, R.S.; Graham, B.S.; McDermott, A.B.; Douek, D.C.; Kwong, P.D.; Mascola, J.R.; Sullivan, N.J.; Misasi, J. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science, 2021, 373(6556), eabh1766.
[http://dx.doi.org/10.1126/science.abh1766] [PMID: 34210892]
[12]
Cox, M.; Peacock, T.P.; Harvey, W.T.; Hughes, J.; Wright, D.W.; Consortium, C.-G. U; Willett, B.J.; Thomson, E.; Gupta, R.K.; Peacock, S.J.; Robertson, D.L.; Carabelli, A.M. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol., 2022, 1-13.
[13]
Goldberg, Y.; Mandel, M.; Bar-On, Y.M.; Bodenheimer, O.; Freedman, L.; Haas, E.J.; Milo, R.; Alroy-Preis, S.; Ash, N.; Huppert, A. Waning immunity after the BNT162b2 vaccine in Israel. N. Engl. J. Med., 2021, 385(24), e85.
[http://dx.doi.org/10.1056/NEJMoa2114228] [PMID: 34706170]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy